权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Academic Palliative Care

学术姑息治疗

基本信息

批准号：
7269523
负责人：
CHARLES F VON GUNTEN
金额：
$ 14.41万
依托单位：
SAN DIEGO HOSPICE AND PALLIATIVE CARE
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-09-01 至 2009-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7269523
关键词：
Acupuncture procedure Address Advocacy American Appendix Area Attitude California Chairperson Commit Communication Competence Comprehensive Cancer Center Development Distress Doctor of Philosophy Education Educational Curriculum Educational process of instructing Evaluation Faculty Family Fostering Funding Future Goals Grant Hospice Care Hour Institute of Medicine (U.S.)Internal Medicine Intractable Pain Journals Knowledge Leadership Legal Lidocaine Malignant Neoplasms Measures Medical Education Medical Students Mentors Methods Modeling National Cancer Institute National Cancer Policy Board Nurse Practitioners Nurses Outcome Palliative Care Palliative Medicine Patient Care Patient Self-Report Patients Pattern Physicians Positioning Attribute Prevention Prevention approach Publications Range Reporting Research Research Design Research Infrastructure Research Peer Review Research Personnel Role Rotation Scientist Score Social Workers Students Support of Research Symptoms Terminal Disease Testing Time Training Universities Week cancer therapy day enteropathogenic Escherichia coli hospice environment improved instrument interest medical schools member painful neuropathy programs research and development skills university student

项目摘要

DESCRIPTION (provided by applicant): Charles F. von Gunten, MD, PhD is seeking support as an established investigator in palliative care, part of National Cancer Institute's prevention and control program. Palliative care can be summarized as the prevention and relief of suffering. As an established investigator with a track record of funded research, peer-reviewed publications and mentoring, he is now in a unique position to foster further development of the field as called for in the recent reports by the Institute of Medicine and National Cancer Policy Board. In roles as Director of the Center for Palliative Studies at San Diego Hospice & Palliative Care, a teaching and research affiliate of the University of California San Diego School of Medicine, member of the NCI-designated University of California San Diego Moores Comprehensive Cancer Center, Co-Principal of the EPEC Project, Senior Associate Editor of the Journal of Palliative Medicine and Chairman, American Board of Hospice and Palliative Medicine, the NCI is able to protect his abilities to conduct palliative care research and mentor trainees and leaders in the field. He has pursued research objectives to understand education (particularly physicians) and symptom control (particularly neuropathic pain) and as well as broad advocacy and leadership objectives to achieve his goals. Scientifically supported approaches to the prevention and relief of suffering are as important to the overall care of patients with cancer and their families as are approaches to the treatment of cancer itself. He needs protected time to continue a vital research program in the creation and dissemination of palliative care knowledge and reentering new physician scientists in the field. He is responsible for the educational and research developments in the largest department of subspecialist palliative medicine physicians in the USA. In addition, he is responsible for nurturing and developing nurse practitioners, nurses, social workers, and chaplains in a similar way. His personal research plan addresses the question "How is palliative care best taught?" This K05 will permit him to conduct educational research for resident physicians, physician fellows, nurses, social workers and chaplains. This K05 will permit him to mentor junior investigators in projects to test the ability of infusional lidocaine to relieve severe refractory pain, to understand patient, family, staff communication in terminal illness, and to test the ability of acupuncture to relieve distress in patients with terminal illness. All reentered investigators are seeking NCI funding and have the potential to become independent investigators.

描述(由申请人提供)：Charles F.von Gunten，医学博士，博士，正在寻求作为姑息治疗方面的一名知名研究员的支持，这是国家癌症研究所预防和控制计划的一部分。姑息治疗可以概括为预防和缓解痛苦。作为一名久负盛名的研究人员，他在资助研究、同行评议出版物和指导方面的记录，现在处于一个独特的地位，可以促进该领域的进一步发展，正如医学研究所和国家癌症政策委员会最近的报告所呼吁的那样。在担任圣地亚哥临终关怀和姑息治疗中心主任、加州大学圣地亚哥医学院的教学和研究分支机构、NCI指定的加州大学圣地亚哥·摩尔综合癌症中心成员、EPEC项目联合负责人、《姑息医学杂志》高级副主编和美国临终关怀和姑息医学委员会主席期间，NCI能够保护他进行姑息治疗研究的能力，并指导受训者和该领域的领导者。他追求研究目标，以了解教育(特别是医生)和症状控制(特别是神经性疼痛)，以及广泛的宣传和领导目标，以实现他的目标。科学支持的预防和减轻痛苦的方法与治疗癌症的方法本身一样，对癌症患者及其家人的整体护理也同样重要。他需要有保护的时间来继续一项重要的研究计划，创造和传播姑息治疗知识，并重新进入该领域的新内科科学家。他负责美国最大的姑息医学专科医师部门的教育和研究发展。此外，他还负责以类似的方式培养和发展执业护士、护士、社会工作者和牧师。他的个人研究计划解决了这样一个问题：“姑息治疗如何才是最好的教育？”这个K05将允许他为住院医生、医师研究员、护士、社会工作者和牧师进行教育研究。这一K05将允许他在项目中指导初级调查人员，以测试输注利多卡因缓解严重顽固性疼痛的能力，了解晚期疾病中患者、家庭、员工的沟通，以及测试针灸缓解晚期疾病患者痛苦的能力。所有重新进入的调查人员都在寻求NCI的资金，并有可能成为独立调查人员。